News

Artificial intelligence is tackling one of the main limitations of wireless charging: its lack of reliability. A fully ...
According to the latest information from the National Intellectual Property Administration, Beijing Jingwei Hengrun Technology Co., Ltd. applied for a patent titled "Method and Device for Generating ...
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...
Alphabiome's proprietary algorithm analyzed trillions of genetic data points and identified over 10,000 complex microbe-derived biomarkers related to the successful use of these drugs.
The growing field of GenAI, or genetic AI, uses advanced algorithms based on machine learning and other systems to match up molecules with conditions in patient groups.
Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants. The method allows persons with high risk of disease to be distinguished more ...
Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.